Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Proteovant Therapeutics Inc.

Headquarters: New York, NY, United States of America
Website: N/A
Year Founded: 2021
Status: Acquired

BioCentury | Feb 10, 2023
Discovery & Translation

Targeting PIKFYVE and SYF2 for ALS; plus new protein degraders and more

BioCentury's roundup of translational news
BioCentury | May 3, 2022
Management Tracks

Jansen to retire from Pfizer

Plus Patel leaves FDA and updates from Roivant, Aldeyra, Omega and more
BioCentury | Mar 1, 2022
Deals

Feb. 28 Quick Takes: Heidelberg shares jump as Huadong takes stake

Plus FDA approves CTI’s pacritinib, Aurinia shares sink, Lexicon submission delayed, priority review for neoadjuvant Opdivo and more
Items per page:
1 - 3 of 3
Help Center
Username
Request a Demo
Request Training
Ask a Question